Genor Biopharma (HKG:6998) said it completed a reverse merger transaction with Edding Group, according to a Hong Kong bourse filing Tuesday.
Under the transaction, Genor Biopharma acquired Edding Group and merged it with a holding company called GenEdd.
The company also changed its name to Edding Genor Group to reflect the merger.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments